Determining Feasibility of Human Myocardial NAD+ Replenishment using Oral Nicotinamide Riboside Supplementation in Adults with Diastolic Dysfunction The CardioNAD Study
Latest Information Update: 15 Mar 2022
At a glance
- Drugs Nicotinamide riboside (Primary)
- Indications Diastolic heart failure
- Focus Pharmacokinetics
- Acronyms The CardioNAD Study
Most Recent Events
- 15 Mar 2022 New trial record